These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 27476001)
1. DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein. Wang B; Huang J; Zhou J; Hui K; Xu S; Fan J; Li L; Wang X; Hsieh JT; He D; Wu K Cell Signal; 2016 Nov; 28(11):1623-30. PubMed ID: 27476001 [TBL] [Abstract][Full Text] [Related]
2. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Xie D; Gore C; Liu J; Pong RC; Mason R; Hao G; Long M; Kabbani W; Yu L; Zhang H; Chen H; Sun X; Boothman DA; Min W; Hsieh JT Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2485-90. PubMed ID: 20080667 [TBL] [Abstract][Full Text] [Related]
3. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Lu MH; Huang CC; Pan MR; Chen HH; Hung WC Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246 [TBL] [Abstract][Full Text] [Related]
4. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma. Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281 [TBL] [Abstract][Full Text] [Related]
5. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability. Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027 [TBL] [Abstract][Full Text] [Related]
6. A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial-Mesenchymal Transition in Prostate Cancer Cells. Melekhova A; Leeder M; Pungsrinont T; Schmäche T; Kallenbach J; Ehsani M; Mirzakhani K; Rasa SMM; Neri F; Baniahmad A Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439818 [TBL] [Abstract][Full Text] [Related]
7. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer. Tang C; Liu T; Wang K; Wang X; Xu S; He D; Zeng J Oncol Rep; 2019 Oct; 42(4):1307-1318. PubMed ID: 31364741 [TBL] [Abstract][Full Text] [Related]
9. The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer. Wang J; Zhu X; Hu J; He G; Li X; Wu P; Ren X; Wang F; Liao W; Liang L; Ding Y Oncotarget; 2015 Sep; 6(29):27427-39. PubMed ID: 26336990 [TBL] [Abstract][Full Text] [Related]
10. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer. Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738 [TBL] [Abstract][Full Text] [Related]
11. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
12. Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop. Fan X; Wang Y; Fan J; Chen R J Cell Biochem; 2019 Jun; 120(6):10643-10651. PubMed ID: 30672020 [TBL] [Abstract][Full Text] [Related]
13. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition. Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of IQGAP1 inhibits epithelial-mesenchymal transition via the HIF1α/VEGF-A signaling pathway in gastric cancer. Liu J; Ni X; Li Y; Chen M; Chen W; Wu Y; Chen B; Wu Y; Xu M J Cell Biochem; 2019 Sep; 120(9):15790-15799. PubMed ID: 31090961 [TBL] [Abstract][Full Text] [Related]
15. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth. Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs and epithelial-mesenchymal transition in prostate cancer. Sekhon K; Bucay N; Majid S; Dahiya R; Saini S Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490 [TBL] [Abstract][Full Text] [Related]
17. HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition. Hao M; Li Y; Wang J; Qin J; Wang Y; Ding Y; Jiang M; Sun X; Zu L; Chang K; Lin G; Du J; Korinek V; Ye DW; Wang J J Pathol; 2017 Aug; 242(4):409-420. PubMed ID: 28466555 [TBL] [Abstract][Full Text] [Related]
18. The role of DAB2IP in androgen receptor activation during prostate cancer progression. Wu K; Liu J; Tseng SF; Gore C; Ning Z; Sharifi N; Fazli L; Gleave M; Kapur P; Xiao G; Sun X; Oz OK; Min W; Alexandrakis G; Yang CR; Hsieh CL; Wu HC; He D; Xie D; Hsieh JT Oncogene; 2014 Apr; 33(15):1954-63. PubMed ID: 23604126 [TBL] [Abstract][Full Text] [Related]
19. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization. Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179 [TBL] [Abstract][Full Text] [Related]
20. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells. Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]